Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for preventing and treating cerebrovascular dementia

A technology for cerebrovascular dementia and drugs, which is applied in drug combinations, medical raw materials derived from leeches/helminths, and pharmaceutical formulations, etc., can solve the problems of difficulty in popularization, high cost, and unbearable for patients.

Inactive Publication Date: 2004-11-17
马合奎
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Then it is not ideal for severe patients, and the cost is too high for patients to bear, so the treatment is terminated. The condition is getting worse and worse, it is still difficult to popularize, and most of the long-term curative effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] Preparation of raw materials used in the present invention: Ginseng 8g, Panax notoginseng 5g, Schisandra 6g, Cornus officinalis 10g, Rehmannia glutinosa 20g, Shouwu 15g, Cordyceps 8g, fried Eucommia 11g, antler 2g, leech 1.5g, Shichangpu 6g, Polygala 3g, Danshen 10g, turtle shell 20g. The above-mentioned medicines are made into dense pills through the traditional process of traditional Chinese medicine, and each pill weighs 3.5g.

[0022] The present invention is through clinical observation and experiment, and result is as follows:

[0023] 1. Selected clinical cases: in line with the diagnostic criteria of the International Classification of Diseases (ICD-10) as mild to moderate dementia, referring to the Hasegawa Dementia Scale (HDC), and presented at the National Symposium on Alzheimer's Disease in Beijing in May 1990 Based on the revised "Diagnosis and Curative Effect Evaluation Criteria of Alzheimer's Disease" (see "Journal of Traditional Chinese Medicine" Volume...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a kind of medicine for preventing and curing cerebrovascular dementia. The materials are: ginseng 3-9g, pseudo-ginseng 3-9g, the fruit of Chinese magnoliavine 3-9g, cornus 6-15g, boiled glutinous rehmannia 10-30g, polygonum ultiforun 10-20g, aweto 5-10g fried gutta-percha 10-15g, pilose deer horn 1-3g, leech 1.5-3g, stone calamus 5-10g, polygala root 3-10g, salvia miltiorrhiza 3-15g, tortoise plastron 10-30g. The invention uses the speciality of the Chinese traditional medicine to enhance the oxygen absorbing ability under ordinary pressure and improve the micro-circulation of meninges, enhance the imminity and memory. It not only can cure the cerebrovascular dementia effectively, but also can prevent the disease.

Description

Technical field [0001] The invention belongs to a traditional Chinese medicine, and mainly relates to a medicine for preventing and treating cerebrovascular dementia. Background technique [0002] Currently, cerebrovascular dementia is one of the three major diseases leading to senile disability. The prevalence of dementia in the elderly over 60 years old in my country is about 5%, and cerebrovascular dementia accounts for more than 60% of all senile diseases, which seriously endangers the life and health of the elderly. At the end of the 20th century, the advent of cerebrolysin established a milestone in the treatment of cerebral blood dementia and senile dementia in neurology. So far, cerebrolysin and cerebrolysin preparations are still the first-choice drugs for the treatment of cerebrovascular dementia, and they have a certain curative effect on mild patients. Then it is not ideal for severe patients, and its cost is high, which makes it difficult for the patient to be...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K35/36A61K35/586A61K35/62A61P25/28
Inventor 马合奎
Owner 马合奎
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products